全文获取类型
收费全文 | 5697篇 |
免费 | 413篇 |
国内免费 | 60篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 149篇 |
妇产科学 | 196篇 |
基础医学 | 694篇 |
口腔科学 | 164篇 |
临床医学 | 629篇 |
内科学 | 1367篇 |
皮肤病学 | 86篇 |
神经病学 | 335篇 |
特种医学 | 440篇 |
外科学 | 717篇 |
综合类 | 160篇 |
预防医学 | 194篇 |
眼科学 | 156篇 |
药学 | 385篇 |
中国医学 | 38篇 |
肿瘤学 | 403篇 |
出版年
2023年 | 18篇 |
2022年 | 46篇 |
2021年 | 110篇 |
2020年 | 73篇 |
2019年 | 92篇 |
2018年 | 145篇 |
2017年 | 105篇 |
2016年 | 127篇 |
2015年 | 243篇 |
2014年 | 215篇 |
2013年 | 244篇 |
2012年 | 392篇 |
2011年 | 372篇 |
2010年 | 251篇 |
2009年 | 175篇 |
2008年 | 285篇 |
2007年 | 297篇 |
2006年 | 272篇 |
2005年 | 251篇 |
2004年 | 235篇 |
2003年 | 298篇 |
2002年 | 263篇 |
2001年 | 197篇 |
2000年 | 175篇 |
1999年 | 139篇 |
1998年 | 78篇 |
1997年 | 65篇 |
1996年 | 62篇 |
1995年 | 46篇 |
1994年 | 44篇 |
1993年 | 49篇 |
1992年 | 94篇 |
1991年 | 74篇 |
1990年 | 69篇 |
1989年 | 76篇 |
1988年 | 69篇 |
1987年 | 69篇 |
1986年 | 57篇 |
1985年 | 34篇 |
1984年 | 23篇 |
1983年 | 27篇 |
1982年 | 18篇 |
1981年 | 20篇 |
1980年 | 19篇 |
1979年 | 27篇 |
1978年 | 18篇 |
1977年 | 17篇 |
1976年 | 10篇 |
1973年 | 9篇 |
1972年 | 10篇 |
排序方式: 共有6170条查询结果,搜索用时 156 毫秒
81.
腹膜外结肠造口一期乳头成形术的临床效果 总被引:4,自引:1,他引:3
目的探讨腹膜外结肠造口加一期乳头成形术的临床效果。②方法对51例肛管和直肠癌病人施行腹膜外结肠造口一期乳头成形术,并与施行传统Miles腹膜内结肠造口术40例病人的效果进行比较,观察造口并发症和排便功能改善情况。③结果51例腹膜外结肠造口术病人经1~5年的随访,仅有1例发生造口旁疝,并发症的发生率为1.9%,40例病人获排便感。对照组各种并发症的发生率为30.0%,无1例病人有排便感。两组比较差异有极显著性(χ2=13.80,P<0.001)。④结论腹膜外结肠造口一期乳头成形术具有并发症少,排便功能好,易于术后管理等优点。 相似文献
82.
S Saika Y Kawashima Y Okada K Ohkawa O Yamanaka T Katoh Y Ohnishi A Ooshima W W Kao 《Cornea》1999,18(3):343-352
PURPOSE: The dysplastic corneal epithelium is characterized by the abnormal proliferation of epithelial cells. The phenotypes of these cells have not been elucidated. We investigated whether such epithelium expresses the phenotypes of corneal or conjunctival epithelial cells. METHODS: The corneas and conjunctivae from four normal subjects and from one patient with epithelial dysplasia of the central cornea were immunostained for IV and VII collagens and for cytokeratins. Monoclonal antibodies against collagen IV reacted to the [alpha1(IV)]2alpha2(IV) or alpha5(IV) molecule. Anti-cytokeratin antibodies were used to define epithelial cell types. The ultrastructure of the basement membrane (BM) of each specimen also was examined. RESULTS: Type VII collagen immunoreactivity was detected in all the specimens of epithelial BM. The anti-collagen IV [alpha1(IV)]2alpha2(IV) antibody labeled the conjunctival BMs, not the BMs of the corneal epithelia, of each subject. The normal corneal epithelial BM, not the BM of the conjunctival or dysplastic corneal epithelium, was immunolabeled with anti-alpha5(IV) antibody. The pattern of cytokeratin expression in the corneal epithelial dysplasia resembled that seen in the normal conjunctivae. Small breaks in the BM of dysplastic corneal epithelium were ultrastructurally revealed. The number of hemidesmosomes in the dysplastic corneal epithelium was decreased as compared with that in the normal BM. CONCLUSION: The composition of collagen types within the BM and the cellular phenotype of the dysplastic epithelium in the cornea resembled those of conjunctival epithelium, not of the cornea. 相似文献
83.
Pathways to care for alcohol use disorders 总被引:1,自引:0,他引:1
84.
The effects of 24-hr exposures to 5-fluorouracil (FUra) and paclitaxel in various sequences were studied in MCF-7 breast cancer cells to determine an optimal schedule for possible clinical use. In clonogenic assays, pre-exposure to FUra followed by paclitaxel resulted in marked antagonism, while sequential paclitaxel followed by FUra was optimal. Concurrent or pre-exposure to paclitaxel did not affect [3H]FUra metabolism, [3H]FUra-RNA incorporation, or the extent of FUra-mediated thymidylate synthase inhibition. Paclitaxel led to G2/M phase accumulation that persisted for up to 24 hr after drug exposure, while a 24-hr FUra exposure produced S-phase accumulation. FUra pre-exposure diminished paclitaxel-associated G2/M phase block, whereas subsequent exposure to FUra after paclitaxel did not. FUra exposure resulted in transient induction of p53 and p21, which returned to basal levels 24 hr after drug removal. p53 and p21 protein content also increased markedly during paclitaxel exposure, accompanied by phosphorylation of Bcl-2. Double-stranded DNA fragmentation (approximately 50 kb) was seen at 48 hr when cells were exposed to paclitaxel for an initial 24-hr period. Paclitaxel-associated DNA fragmentation was not prevented by concurrent or subsequent exposure to FUra. Thus, paclitaxel-mediated G2/M phase arrest appeared to be a crucial step in induction of DNA fragmentation. Since an initial 24-hr paclitaxel exposure did not interfere with subsequent FUra metabolism or thymidylate synthase inhibition, and delayed exposure to FUra did not impede either paclitaxel-mediated induction of mitotic blockade or DNA fragmentation, the sequence of paclitaxel followed by FUra is recommended for clinical trials. 相似文献
85.
Purpose
Mivacurium is metabolized by plasma cholinesterase catalyzed ester hydrolysis. Acetylcholinesterase antagonists used in the reversal of muscle relaxation may also inhibit plasma cholinesterase and, therefore, delay the hydrolysis of mivacurium. The clinical interaction between acetylcholinesterase antagonists and mivacurium induced neuromuscular blockade was studied.Method
Intraoperative muscle relaxation was maintained with a mivacurium infusion to achieve a constant intense block (first twitch, T1, 2–3% of control). Patients were randomly divided into three groups. Patients in Group 1 received no anticholinesterase, in Group 2 neostigmine 0.07 mg · kg?1, and in Group 3 edrophonium 1 mg · kg?1. The times between termination of the mivacurium infusion (Group 1) or the administration of the anticholinesterase (Groups 2 and 3) to 25%, 50%, 75% and 95% T1 recovery, and to 50%, 70% and 90% recovery in the ratio, T4/T1 (TR) were recorded.Result
In the neostigmine Group, T1 recovery to 25%, 50% and 75% ( 2.32 ± 1.41, 3.90 ± 1.85 and 6.88 ± 2.66 min) was accelerated compared with control (3.36 ± 1.34, 5.78 ± 2.22, and 8.58 ± 3.60, and), but recovery to 95% (18.53 ± 9.09 vs 13.29 ± 5.24 min) was delayed. Also, TR recovery to 50%, 70%, and 90% was slower (14.47 ± 8.73, 21.25 ± 11.06 and 31.37 ± 12.11 min vs 11.75 ± 3.74, 13.78 ± 4.39 and 17.86 ± 6.44 min). However, all T1 and TR recovery times were decreased in the edrophonium group (0.88 ± 0.51, 2.00 ± 1.50, 4.97 ± 2.96, and 9.35 ± 5.24 min for T1 and 6.86 ± 3.93, 9.05 ± 4.51 and 12.24 ± 6.66 min for TR).Conclusion
Neostigmine reversal of intense mivacurium neuromuscular block should be avoided, as this may result in prolongation of the block. 相似文献86.
Chia-Hung Kao Chih-Kua Huang Shyh-Jen Wang Chung-Yuan Hsu Wan-Yu Lin Gran-Hum Chen 《European journal of nuclear medicine and molecular imaging》1993,20(8):708-711
Urease in the human gastric mucosa is a marker for infection with Helicobacter pylori (HP), an organism which is associated with peptic ulcer disease. To detect gastric urease, we examined 184 patients (144 males, 40 females; mean age: 49.8±15.6 years) with suspected peptic ulcer disease. Fasting patients were given orally 5 Ci of carbon-14 labelled urea. From each patient only one breath sample was collected in hyamine at 10 min. The amount of 14C collected at 10 min was expressed as follows: [(DPM/mmol CO2 collected)/(DPM administered)] × 100 × body weight (kg). The presence of HP colonization was determined by examination of multiple endoscopic prepyloric antral biopsy specimens subjected to culture or a rapid urease test. For the purpose of this study, HP-positive patients were defined as those with characteristic bacteria as indicated by a positive result of either the culture or the rapid urease test; HP-negative patients were defined as those with negative findings on both the culture and the rapid urease test. Of the 184 cases, 99 (53.8%) were positive for HP infection, and 85 (46.2%), negative. The sensitivity and specificity of the rapid 10 min 14C-urea breath test for the diagnosis of HP-associated peptic ulcer disease were evaluated by a receiver operating characteristic (ROC) curve with a variable cut-off value from 1.5 to 4.5. When a cut-off value of 1.5 was selected, the sensitivity was 100% and the specificity, 83.5%; when a cut-off value of 4.5 was selected, the sensitivity was 54.5% and the specificity, 97.6%.
Correspondence to: Chia-Hung Kao 相似文献
87.
Time course of satisfaction of search 总被引:2,自引:0,他引:2
K S Berbaum E A Franken D D Dorfman S A Rooholamini C E Coffman S H Cornell A H Cragg J R Galvin H Honda S C Kao 《Investigative radiology》1991,26(7):640-648
"Satisfaction of search" (SOS) refers to the effect in which a second lesion remains undetected after detection of another lesion on the same radiograph. The objective of this study was to clarify our understanding of SOS by relating it to total time of inspection and time intervals before, between, and after discovery of lesions. Detection accuracy of native lesions in chest radiographs, before and after the addition of a simulated nodular lesion, was measured for ten observers. Analysis of data from this and a previous experiment showed that average perceptual accuracy of individual receiver operating characteristic curves was significantly reduced with the addition of the nodules. Plots and analyses of search time revealed that, on average, during a typical 46-second inspection of a case, simulated nodules were found at 18 seconds, native abnormalities at 25 seconds, and false positives occurred at 33 seconds. Time needed to find nodules did not depend on whether native lesions were present; time to find native lesions did not change with addition of nodules; and total search time was the same for images with one, two, or no lesions. The detection results show that the SOS effect was obtained, but that interrupting search in order to measure it also diminishes accuracy. Analysis of the time course data relates SOS to perceptual capture and strategic halting of search. 相似文献
88.
J S Kroin L C Kao T J Zhang R D Penn H L Klawans P M Carvey 《Journal of neurosurgery》1991,74(1):105-111
In an effort to verify the "dopamine secretion hypothesis" as the mechanism responsible for the antiparkinsonian efficacy of adrenal medullary transplants into the brain, the effects of dopamine infusion into the brains of rats with unilateral substantia nigra lesions were examined. The apomorphine-induced rotation, characteristic of this animal model, was diminished after 7 days of continuous dopamine infusion (10 micrograms/hr) into the ipsilateral striatum, whereas intraventricular infusion was without effect. Chromatographic analysis of the dopamine distribution after 10 days of infusion into either region revealed that ipsilateral delivery of dopamine did not result in contralateral increases in dopamine content. Examination of the adjacent striatum following ipsilateral intraventricular delivery indicated that dopamine had only penetrated 1 mm. Even with intrastriatal delivery, there were still parts of the infused striatum which had below-normal levels of dopamine. The fact that striatal tissue presents a significant barrier to the penetration of dopamine is discussed in relation to adrenal medullary and fetal nigral transplants. 相似文献
89.
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. 总被引:12,自引:0,他引:12
Thorir D Bjornsson John T Callaghan Heidi J Einolf Volker Fischer Lawrence Gan Scott Grimm John Kao S Peter King Gerald Miwa Lan Ni Gondi Kumar James McLeod R Scott Obach Stanley Roberts Amy Roe Anita Shah Fred Snikeris John T Sullivan Donald Tweedie Jose M Vega John Walsh Steven A Wrighton 《Drug metabolism and disposition》2003,31(7):815-832
Current regulatory guidances do not address specific study designs for in vitro and in vivo drug-drug interaction studies. There is a common desire by regulatory authorities and by industry sponsors to harmonize approaches, to allow for a better assessment of the significance of findings across different studies and drugs. There is also a growing consensus for the standardization of cytochrome P450 (P450) probe substrates, inhibitors and inducers and for the development of classification systems to improve the communication of risk to health care providers and to patients. While existing guidances cover mainly P450-mediated drug interactions, the importance of other mechanisms, such as transporters, has been recognized more recently, and should also be addressed. This article was prepared by the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism and Clinical Pharmacology Technical Working Groups and represents the current industry position. The intent is to define a minimal best practice for in vitro and in vivo pharmacokinetic drug-drug interaction studies targeted to development (not discovery support) and to define a data package that can be expected by regulatory agencies in compound registration dossiers. 相似文献
90.